ResearcherUniversity Hospital in HalleActive in the last 2 years
Monika Hämmerle
Matched on ORCID iD 0000-0003-3145-0541; OpenAlex author ID A5111680770, A5134957062. Sources: OpenAlex.
Their work
- Papers
- 8 (first author 0, last author 3)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 19
2020: 2 papers · 2021: none · 2022: 1 paper · 2023: 1 paper · 2024: 1 paper · 2025: 1 paper · 2026: 2 papers
Papers 8
- FOXM1 regulates platelet-induced anoikis resistance in pancreatic cancer cells. Last author DOI 10.1186/s12964-025-02644-8↗
- Multi-level Analysis of Codon Usage Patterns Reveals Systematic Optimization of Oncogenic Gene Expression in Pancreatic Cancer Co-author DOI 10.64898/2026.04.24.720399↗
- Innate Immunity and Platelets: Unveiling Their Role in Chronic Pancreatitis and Pancreatic Cancer. Last author DOI 10.3390/cancers17101689↗
- Periostin is associated with prognosis and immune cell infiltration in pancreatic adenocarcinoma based on integrated bioinformatics analysis. Co-author DOI 10.1002/cnr2.1990↗
- Gender-specific changes of the gut microbiome correlate with tumor development in murine models of pancreatic cancer. Co-author DOI 10.1016/j.isci.2023.106841↗
- Single Cell Analysis of Cultivated Fibroblasts from Chronic Pancreatitis and Pancreatic Cancer Patients. Co-author DOI 10.3390/cells11162583↗
- LINC00261 Is Differentially Expressed in Pancreatic Cancer Subtypes and Regulates a Pro-Epithelial Cell Identity. Last author DOI 10.3390/cancers12051227↗
- Comprehensive Analysis of LincRNAs in Classical and Basal-Like Subtypes of Pancreatic Cancer. Co-author DOI 10.3390/cancers12082077↗
Closest collaborators
The 19 strongest of 19 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Tony Gutschner · 4 shared papers, 2020–2026 · strength 0.96
- Paper Multi-level Analysis of Codon Usage Patterns Reveals Systematic Optimization of Oncogenic Gene Expression in Pancreatic… DOI 10.64898/2026.04.24.720399↗
- Paper FOXM1 regulates platelet-induced anoikis resistance in pancreatic cancer cells. DOI 10.1186/s12964-025-02644-8↗
- Paper Comprehensive Analysis of LincRNAs in Classical and Basal-Like Subtypes of Pancreatic Cancer. DOI 10.3390/cancers12082077↗
- Markus Glaß · 3 shared papers, 2020–2026 · strength 0.63
- Paper Multi-level Analysis of Codon Usage Patterns Reveals Systematic Optimization of Oncogenic Gene Expression in Pancreatic… DOI 10.64898/2026.04.24.720399↗
- Paper Comprehensive Analysis of LincRNAs in Classical and Basal-Like Subtypes of Pancreatic Cancer. DOI 10.3390/cancers12082077↗
- Paper LINC00261 Is Differentially Expressed in Pancreatic Cancer Subtypes and Regulates a Pro-Epithelial Cell Identity. DOI 10.3390/cancers12051227↗
- Stefan Hüttelmaier · 3 shared papers, 2020–2026 · strength 0.63
- Paper Multi-level Analysis of Codon Usage Patterns Reveals Systematic Optimization of Oncogenic Gene Expression in Pancreatic… DOI 10.64898/2026.04.24.720399↗
- Paper Comprehensive Analysis of LincRNAs in Classical and Basal-Like Subtypes of Pancreatic Cancer. DOI 10.3390/cancers12082077↗
- Paper LINC00261 Is Differentially Expressed in Pancreatic Cancer Subtypes and Regulates a Pro-Epithelial Cell Identity. DOI 10.3390/cancers12051227↗
- Yijun Chen · 2 shared papers, 2022–2024 · strength 0.41
- Yoshiaki Sunami · 2 shared papers, 2022–2024 · strength 0.41
- Jorg H. Kleeff · 2 shared papers, 2022–2024 · strength 0.41
- Sebastian Krug · 2 shared papers, 2023–2025 · strength 0.41
- Lisa Mueller · 1 shared paper, 2026 · strength 0.36
- Pit Preckwinkel · 1 shared paper, 2026 · strength 0.36
- Alissa Ernesti-Soldatkin · 1 shared paper, 2026 · strength 0.33
- Ágnes Dorn · 2 shared papers, 2020 · strength 0.27
- Juliane Blümke · 1 shared paper, 2025 · strength 0.25
- Ivonne Bazwinsky‐Wutschke · 1 shared paper, 2025 · strength 0.25
- Elise Arlt · 1 shared paper, 2025 · strength 0.25
- Sonja M. Kessler · 1 shared paper, 2025 · strength 0.25
- Tom Kaune · 1 shared paper, 2023 · strength 0.16
- Heidi Griesmann · 1 shared paper, 2023 · strength 0.16
- Jonas Rosendahl · 1 shared paper, 2023 · strength 0.16
- Patrick Michl · 1 shared paper, 2023 · strength 0.16
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.